Uncategorized
New toric IOL shows stability, safety and efficacy
LOS ANGELES — The new Bausch + Lomb enVista toric IOL met all safety and efficacy endpoints in a pivotal FDA trial, according to a presentation here. “Premarket approval application to the FDA is underway,” Richard Hope, MD, said at the American Society of Cataract and Refractive Surgery meeting.